billHRES1365Event Thursday, June 11, 2026Analyzed

Recognizing Avoidant/Restrictive Food Intake Disorder (ARFID) as a serious feeding and eating disorder and acknowledging the urgent need to advance awareness, early identification, research, and equitable access to care.

Neutral

Summary

HRES1365 is an early-stage resolution recognizing ARFID as a serious eating disorder. It contains no authorizations, appropriations, or regulatory mandates. The bill has only been referred to two committees and lacks the legislative mechanisms to directly affect any publicly traded company's revenue or operations.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HRES1365 is a symbolic resolution with zero funding, no mandates, and no regulatory impact.
  • 2.No publicly traded company faces direct revenue, cost, or competitive changes from this bill.
  • 3.The bill is in the earliest legislative stage with no clear path to enactment that would affect markets.

Market Implications

This resolution has no market implications. No sector, company, or security is affected. The bill does not create, eliminate, or modify any market mechanism, funding stream, or regulatory requirement. Investors should allocate attention to bills with actual authorizations or appropriations.

Full Analysis

What happened: On June 11, 2026, Rep. Velázquez (D-NY-7) introduced House Resolution 1365, a non-binding resolution recognizing Avoidant/Restrictive Food Intake Disorder as a serious condition and urging awareness and equitable access to care. The bill was referred to the Energy and Commerce and Education and Workforce Committees. It has two cosponsors and is in the earliest legislative stage with no hearings or markups scheduled.

The money trail: This resolution authorizes zero dollars. It does not create any program, mandate, tax credit, or funding stream. It is a sense-of-Congress resolution with no budgetary impact. No subsequent appropriation is required or enabled.

Structural winners and losers: None. The bill does not impose compliance costs, alter market access, create subsidies, or change regulations for any industry. Companies in eating disorder treatment (e.g., Acadia Healthcare, eating disorder clinics) or nutritional supplement makers are not directly affected because the resolution does not mandate insurance coverage, increase research funding, or establish any payment mechanism.

Timeline: As a resolution in its first week, it requires committee hearings, a vote, and passage in the House. Even if passed, it remains non-binding. The Senate has no companion bill. No market-relevant legislative action is imminent.

Key Legislators

Rep. Velázquez, Nydia M. [D-NY-7]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Exec OrderMay 29, 2026

Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries

This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.

Exec OrderApr 30, 2026

Promoting Efficiency, Accountability, and Performance in Federal Contracting

This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →